Jun 21, 2008
AmVac, Icon Genetics Team on Plant-Based Influenza Vaccine
Swiss vaccine developer AmVac AG is teaming up with Bayer AG subsidiary Icon Genetics GmbH to develop a plant-based production system for making an adjuvanted influenza vaccine.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Lawsuits seek damages from Bayer over anti-blee... | Apr '08 | Muckraker462 | 1 |
| Bayer's 1st-quarter profit slides by 73 percent... | Apr '08 | Muckraker462 | 1 |
| Bayer units file infringement lawsuit in US cou... | Apr '08 | Muckraker462 | 1 |
| Bayer stops late-stage Nexavar trial (from Feb '08) | Feb '08 | gdpawel | 1 |
